@misc{indiciaefc98a04f4c2a,
  title = {Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.},
  author = {Raphael J Landovitz and Yvett Pinedo and Federico Hinestrosa and Gordon E Crofoot and Cynthia Brinson and Susan Buchbinder and Jean-Michel Molina and Ronnie M Gravett and James B Brock and Moti N Ramgopal and A Lina Rosengren and Igho Ofotokun and Jose Valdez Madruga and Geoffroy Liegeon and Ravindre Panchia and Khuanchai Supparatpinyo and Anchalee Avihingsanon and Catherine Creticos and Shobha Swaminathan and Susanne Doblecki-Lewis and Jorge Rodriguez and Marc Siegel and Shinichi Oka and Thanyawee Puthanakit and Beatriz Grinsztejn and Eduard J Sanders and Javier R Lama and Johannes Lombaard and Nkosiphile Ndlovu and Peggy Hwang and Jiejun Du and Beth Jackson and Brenda Homony and Barbara Evans and Peter Sklar and Michael N Robertson and Rebeca M Plank},
  year = {2026},
  doi = {10.1093/cid/ciag171},
  url = {https://pubmed.ncbi.nlm.nih.gov/41830344/},
  note = {Source identifier: 41830344}
}